Evidence map›Paper›PMID 39785092›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2025

Perilipin-1 autoantibodies are a robust marker of acquired lipodystrophy and may precede clinical detection.

Clément Triaille, Fernando Corvillo, Ann Mertens, Ilse Hoffman, Tania Roskams, Margarita López-Trascasa, Lien De Somer, Kristina Casteels

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Perilipin-1 autoantibodies are a robust marker of acquired lipodystrophy and may precede clinical detection.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Clément TriailleDivision of Pediatric Rheumatology, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-9227-3820
Fernando CorvilloComplement Research Group, Hospital La Paz Institute for Health Research (IdiPAZ), La Paz University Hospital, Madrid, Spain.ORCID https://orcid.org/0000-0001-6418-5647
Ann MertensClinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Ilse HoffmanDepartment of Paediatric Gastroenterology & Hepatology & Nutrition, University Hospitals Leuven, Leuven, Belgium.
Tania RoskamsDepartment of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Margarita López-TrascasaComplement Research Group, Hospital La Paz Institute for Health Research (IdiPAZ), La Paz University Hospital, Madrid, Spain.
Lien De SomerDivision of Pediatric Rheumatology, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
Kristina CasteelsDepartment of Pediatrics, University Hospitals Leuven, Leuven, Belgium.

Funding

Asociación Española de Familiares y Afectados de Lipodistrofias (AELIP)CHU Sainte-Justine FoundationFondation médicale Horlait-DapsensWallonie-Bruxelles International
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acquired general lipodystrophyanti‐PLIN1 antibodiesautoimmune hepatitisautoimmune lipodystrophyautoimmunityperlipin1

Identifiers

PMID39785092
PMCPMC11715144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.